Design, optimization of Niosomal gel capability for solubility and bioavailability enhancement of Kynurenic acid after intranasal administration: In Vitro and In Vivo Evaluation
Abstract Background Kynurenic acid (KNA) could be useful in treating neurological diseases; nevertheless, the fact that it couldn’t penetrate the blood-brain barrier (BBB) limits its neuroprotective efficacy. Research is being conducted on drug delivery devices to transport KNA to the brain. Objecti...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-12-01
|
| Collection: | BMC Biotechnology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12896-025-01069-y |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
